• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

For Women with A Personal History of Breast Cancer: Mammography or Breast MRI?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Lack of consensus on breast MRI for routine surveillance in asymptomatic women with a personal history of breast cancer
  • Wernli et al. (Radiology, 2019) compared the performance of breast MRI to mammography alone for women with a personal history of breast cancer

METHODS:

  • Observational cohort study
    • Data derived from Breast Cancer Surveillance Consortium (BCSC)
  • Participants in Consortium
    • ≥18 years of age or older (mean age, 60 years ± 13)
    • Stage 0 to III
    • Underwent mammographic and/or breast MRI exams
  • Groups
    • Mammography alone
    • Breast MRI
  • Primary outcome: Performance measures of the two imaging techniques
    • Calculated by using end-of-day assessment and occurrence of second breast cancer events within 1 year of imaging
  • Data analysis
    • Logistic regression to compare performance for breast MRI versus mammography alone,
      • adjusting for demographics, examination, and primary breast cancer characteristics
    • Analysis was conducted on a per-examination basis

RESULTS:

  • 13,266 women
    • Mammography group: 11,745 | Breast MRI group: 1,521
    • Total examinations: 33,938 mammography | 2506 breast MRI
  • Breast MRI was associated with
    • Younger age at diagnosis
    • Chemotherapy
    • Higher education and income

Raw performance measures (without adjustments) for breast MRI vs mammography were

  • Cancer detection rates (per 1,000 exams)
    • MRI: 10.8 (95% CI, 6.7-14.8)
    • Mammography: 8.2 (95% CI, 7.3-9.2)
  • Sensitivity
    • MRI: 61.4% (27/44) (95% CI, 46.5%-76.2%)
    • Mammography: 70.3% (279/397) (95% CI, 65.8%-74.8%)
  • Biopsy rate
    • Breast MRI: 10.1% (95% CI, 8.9%-11.3%)
    • Mammography: 4.0% (95% CI, 3.7%-4.2%)
  • In multivariable models, breast MRI, compared to mammography alone, was associated with
    • Higher biopsy rate: Odds ratio (OR) of 2.2 (95% CI, 1.9-2.7; P < .001)
    • Higher cancer detection rate: OR of 1.7 (95% CI, 1.1-2.7; P = .03)
    • No difference in sensitivity: OR of 1.1 (95% CI, 0.4-2.9; P = .84)
    • No difference for interval cancer rate: OR of 1.1 (95% CI: 0.6-2.2; P = .70)

CONCLUSION:

  • While surveillance breast MRI resulted in higher biopsy and cancer detection rates in women with a personal history of breast cancer, no differences seen in sensitivity or interval cancer rates
  • The authors conclude

…mammography did not miss more cancers that would become clinically detectable during the 1-year screening interval.

Comparisons of new imaging strategies for surveillance of women with a personal history of breast cancer need to account for differences in women, incident tumor, and treatment characteristics.

Learn More – Primary Sources:

Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Learn More  »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Mammography Guidelines for Average-Risk Women
How Effective Is Mammography in Reducing the Number of Advanced Breast Cancer Diagnoses?
Has Breast Density Legislation Had Any Impact on Breast Cancer Diagnosis? 
Can Ultrasonography in Addition to Mammography Improve Breast Cancer Screening Effectiveness?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site